Gene Defects Determine Susceptibility to Cancer and Bone Marrow Failure
... a gene mutation, Dkc1, that affects ribosome function. Dyskeratosis congenita involves abnormal bone marrow leading to anemia, immune deficiency and ... to study the Dkc1 mutation in cells from humans with dyskeratosis congenita and in a genetically altered mouse model. Ruggero had previously developed ...Telomerase Vital In Maintaining Ability of Stem Cell to Multiply
... are short, and having telomerase doesn't lengthen them right away." The condition in these altered mice bears a close resemblance to dyskeratosis congenita in humans where stem cells in the bone marrow as well as in the intestine are unable to multiply as required and consequently die early. The ...Gene Therapy Improves Vision in Patients with Congenital Retinal Disease
... Trust at the Scheie Eye Institute, the Rosanne H. Silbermann Foundation, the Italian Telethon Foundation, the Associazione Italiana Amaurosi congenita di Leber, the National Center for Research Resources, the Howard Hughes Medical Institute, the National Eye Institute of the National Institutes of ...Peter Baumann named Howard Hughes Medical Institute Early Career Scientist
... research team hopes to lay the foundation for the development of treatments for cancer as well as degenerative syndromes such as dyskeratosis congenita and aplastic anemia. Dr. Baumann leads an eight-person team at the Stowers Institute composed of postdoctoral researchers, graduate students, and ...A little telomerase isn't enough
... develop," says Greider, whose lab reported the role of the critically short telomere in 2001. The usual treatment for people with dyskeratosis congenita is a bone marrow transplant from an unaffected family member. But the team's new findings in mice suggest that the family member chosen for the ...